Clinical Trials Logo

Hypersensitivity clinical trials

View clinical trials related to Hypersensitivity.

Filter by:

NCT ID: NCT03346148 Completed - Food Allergy Clinical Trials

Staff Management About Food Allergy Into ResTaurants

SMART
Start date: December 2016
Phase: N/A
Study type: Observational

Assessment of the knowledge levels of restaurant personnel about food allergies. A structured questionnaire was given through a telephonic interview to evaluate the responses of the respondents.

NCT ID: NCT03344783 Completed - Allergic Disorder Clinical Trials

The Effects of Early Life PUFA and R-TFA on AD: A Systematic Review and Meta-analysis

Start date: March 15, 2017
Phase: N/A
Study type: Observational

The purpose of this study is to evaluate whether early life natural exposure to fatty acid affects the AD risk.

NCT ID: NCT03338855 Completed - Clinical trials for Diabetes Mellitus, Type 2

Effects of 5 Weeks Treatment With Dapagliflozin in Type 2 Diabetes Patients on How the Hormone Insulin Acts on Sugar Uptake in Muscles.

DAPAMAAST
Start date: March 5, 2018
Phase: Phase 4
Study type: Interventional

The purpose of this study is to investigate the effects of 5 weeks treatment with dapagliflozin in type 2 diabetes patients on how the hormone insulin acts on sugar uptake in muscles.

NCT ID: NCT03338621 Completed - Tuberculosis Clinical Trials

Trial to Evaluate the Efficacy, Safety and Tolerability of BPaMZ in Drug-Sensitive (DS-TB) Adult Patients and Drug-Resistant (DR-TB) Adult Patients

Start date: July 30, 2018
Phase: Phase 2/Phase 3
Study type: Interventional

To evaluate the efficacy, safety and tolerability at 8 weeks (2-months), 52 weeks (12-months), and 104 Weeks (24-months) post the start of the following treatment regimens in participants with: Drug Sensitive TB (DS-TB) patients given BPaMZ for 17 Weeks ( or 4 months) vs. Standard HRZE/HR treatment given for 26 weeks (or 6 months) and Drug Resistant TB (DR-TB) patients given BPaMZ for 26 Weeks (or 6 months)

NCT ID: NCT03337542 Completed - Peanut Allergy Clinical Trials

AR101 Real-World Open-Label Extension Study

Start date: October 18, 2017
Phase: Phase 3
Study type: Interventional

This study is enrolling participants by invitation only. This is an open-label, safety extension study for subjects who participated in the ARC007 study.

NCT ID: NCT03323372 Completed - Tooth Sensitivity Clinical Trials

Different Concentrations of Potassium Nitrate in In-office Tooth Bleaching Sensitivity

Start date: December 21, 2016
Phase: Phase 2
Study type: Interventional

The aim of this randomized, double-blind controlled clinical study was to evaluate the absolute risk and intensity of sensitivity to dental bleaching in adults on the application of two different gels based on potassium nitrate and sodium fluoride from a prospective randomized clinical study.

NCT ID: NCT03310268 Completed - Dentin Sensitivity Clinical Trials

A Clinical Study to Evaluate a Stannous Fluoride Toothpaste for the Relief of Dentinal Hypersensitivity

Start date: November 18, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to provide evidence of clinical efficacy of an experimental dentifrice containing stannous fluoride (SnF2) compared to regular fluoride dentifrice in the reduction of dentinal hypersensitivity (DH). This study will be considered successful if there is a statistically significant difference in the primary efficacy variable, change from baseline in Schiff sensitivity score, after 8 weeks of treatment.

NCT ID: NCT03304262 Completed - Healthy Clinical Trials

Metaplasticity Experimental Design and Comparison of Motor Outcome Measure Sensitivity to Change

Start date: July 18, 2017
Phase: N/A
Study type: Interventional

The overall objective is to validate the methodology of a metaplasticity experimental design by assessing change in motor excitability after administration of priming transcranial direct current stimulation (tDCS) followed by repetitive transcranial magnetic stimulation (rTMS) in healthy human participants.

NCT ID: NCT03300583 Completed - Clinical trials for Idiopathic Pulmonary Fibrosis

Toward Self-management in ILD

Start date: June 1, 2018
Phase:
Study type: Observational

Treating and caring for people with long term conditions accounts for a substantial proportion of health care resources. Self-management is advocated as a mechanism that can empower service users with long term conditions to choose healthier options and also transform the relationship between service user and caregivers from one in which the former is a passive recipient of care to one in which they are an active partner in decision-making. Interstitial lung disease (ILD) is one such long term condition. Patients with ILD often express concern about the lack of information on possible rehabilitation programmes and other services that could potentially improve self-management of the disease. In addition, there is a general perception about a lack of co-ordination between health care professionals especially in relation to referral to services for comprehensive management of the disease. Therefore, the needs of patients with ILD and their carers, and possible gaps in service provision need to be explored further. In this study, the investigators propose to explore the needs of ILD patients from all types of ILD and all stages of severity and to also involve carers and clinicians. The investigators will conduct three focus groups for patients and carers and six one-to-one interviews with clinicians to explore perceptions about service gaps and needs in two ILD centres in South and North London, UK. This study will provide valuable information to develop the building blocks of a self-management resource and will enable the investigators to make it specific to the different types of ILD.

NCT ID: NCT03299439 Completed - Knee Osteoarthritis Clinical Trials

Acupuncture Treatment for Knee Osteoarthritis With Sensitive Acupoints and Tender Points

Start date: October 25, 2017
Phase: N/A
Study type: Interventional

The investigators plan to investigate the effectiveness of acupuncture at highly sensitive points, compared with lowly/non-sensitive points or no acupuncture (waiting-list), in improving pain, joint function and quality of life, among patients with KOA. The safety of acupuncture will also be assessed during the study period.